GALC

GALC

Target · Lysosomal enzyme

GALC Galactosylceramidase · Galactocerebrosidase

GALC (galactosylceramidase, also named galactocerebrosidase) is a lysosomal glycoside hydrolase that cleaves galactose ester bonds in glycolipids such as galactosylceramide and galactosylsphingosine. Loss-of-function mutations in the GALC gene are associated with Krabbe disease. Browse Assay Genie's current range of GALC research reagents below, or read on for the biology behind the target.

Lysosomal localisationGlycolipid hydrolaseLinked to Krabbe disease
685 aa
Protein length
~77 kDa
Molecular weight
14q31.3
Gene locus
EC 3.2.1.46
Enzyme class
Target information

What is GALC (galactosylceramidase)?

GALC is a lysosomal enzyme that hydrolyses the galactose ester bonds of glycolipids. Its best-known substrates are galactosylceramide and galactosylsphingosine, and the NCBI Gene summary also lists lactosylceramide and monogalactosyldiglyceride. UniProt describes GALC as an enzyme with very low activity that is responsible for the lysosomal catabolism of galactosylceramide, a major lipid in myelin, kidney and the epithelial cells of the small intestine and colon.

Galactocerebrosidase is classified under EC 3.2.1.46 and belongs to the glycosyl hydrolase 59 family, which sits within the HGNC glycoside hydrolase family gene group. The human GALC protein is found in the lysosome. The mouse ortholog is written Galc, which is relevant for researchers working with rodent models. Alternate transcriptional splice variants of the GALC gene, encoding different isoforms, have been characterised.

The previous HGNC name, galactosylceramidase (Krabbe disease), reflects the clinical importance of the gene. Mutations in GALC have been associated with Krabbe disease, also known as globoid cell leukodystrophy. This link makes GALC a central subject for studies of sphingolipid turnover, myelin lipid catabolism and lysosomal storage disorders.

Krabbe disease research

Mutations in GALC are associated with Krabbe disease, also called globoid cell leukodystrophy, so the enzyme is a primary focus for studying this disorder.

Lysosomal storage disorders

GALC is a lysosomal hydrolase, making it a relevant target for work on lysosomal catabolism and the consequences of enzyme deficiency.

Sphingolipid metabolism

GALC hydrolyses galactosylceramide, galactosylsphingosine and related glycolipids, placing it within studies of glycolipid breakdown.

Myelin lipid biology

Galactosylceramide is a major myelin lipid, and GALC is responsible for its lysosomal catabolism, linking the enzyme to myelin turnover research.

Background

GALC frequently asked questions

What does GALC do?

GALC is a lysosomal hydrolase that cleaves the galactose ester bonds of glycolipids, including galactosylceramide and galactosylsphingosine. UniProt describes it as an enzyme with very low activity that is responsible for the lysosomal catabolism of galactosylceramide, a major lipid in myelin, kidney and intestinal epithelium.

Is GALC the same as galactocerebrosidase?

Yes. Galactosylceramidase is the HGNC full name for GALC, and galactocerebrosidase is the protein name used by UniProt. The earlier HGNC name was galactosylceramidase (Krabbe disease). Alternate splice variants encoding different isoforms of the GALC gene have also been described.

Is GALC linked to disease, and is it conserved in mouse?

Mutations in the GALC gene are associated with Krabbe disease, also known as globoid cell leukodystrophy. The mouse ortholog is Galc, so rodent studies are possible; check the datasheet of any product for its validated reactivity.

Explore

Related targets

Other lysosomal hydrolases and sphingolipid-metabolism enzymes with products at Assay Genie.

Gene and protein annotations from HGNC, NCBI Gene and UniProt P54803; product specifications from Assay Genie datasheets.

GALC Product listing